- Editorial
- Metformin and Statins and their role in reducing Hepatocellular Carcinoma Risk: Randomized trials are needed
- Paul Y. Kwo
- Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, California, USA
- Corresponding author: Paul Y. Kwo ,Tel: 6507237040, Email: pkwo@stanford.edu
- Received: June 4, 2024; Accepted: June 6, 2024.